News & Views

Accord Launches Landmark Study to Redefine Mental Health Treatment at its Metabolic Roots

ACCORD is proud to announce that the Baszucki Group has awarded more than $600,000 in research funding to support a groundbreaking study on metabolic psychiatry in partnership with McLean Hospital. This three-year project, led by Dr. Virginie-Anne Chouinard and Dr. Matthew Bernstein, along with a dedicated research assistant and biostatistician, will explore how ketogenic and other metabolic interventions influence psychiatric symptoms, metabolic health and overall functioning.

New Study of College Students with Depression Adds to Growing Evidence for Ketogenic Therapy as a Mental Health Treatment

The promise of ketogenic therapy for treating mental illness is accelerating with the newly published findings of a pilot study at The Ohio State University, which showed remarkable improvements in symptoms of depression in college students who maintained a ketogenic diet. This is the third recent study to show significant improvements in mental and physical health through ketogenic therapy.

Keto Diet Linked to Reduced Depression Symptoms in College Students

A new study shows an association between at least 10 weeks of following a well-formulated ketogenic diet and a roughly 70% decrease in depression symptoms among a small group of college students

Coalition for Metabolic Health Launches as Part of $50 Million Investment to Tackle America’s Health Crisis

Launched with seed funding from the Baszucki family’s $50 million commitment to improve metabolic health, the Coalition for Metabolic Health (CMH) — an independent alliance of leading scientists, clinicians, and advocates — will put the issue at the center of America’s fight against chronic disease. CMH was conceived by Jan Ellison Baszucki, best-selling author and co-founder of Baszucki Group and Metabolic Mind, and her husband, David Baszucki, founder and CEO of Roblox.

< 1 … 6 7 8 9 10 … 24 >